BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38774792)

  • 1. The Role of Frequent Screening or Diagnostic Testing of Serum Cryptococcal Antigen in Liver Transplant Recipients: A Descriptive Epidemiology.
    Miwa T; Okamoto K; Ikeuchi K; Yamamoto S; Okugawa S; Ichida A; Akamatsu N; Hasegawa K; Tsutsumi T
    Open Forum Infect Dis; 2024 May; 11(5):ofae255. PubMed ID: 38774792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryptococcal Antigen Screening in Asymptomatic HIV-Infected Antiretroviral Naïve Patients in Cameroon and Evaluation of the New Semi-Quantitative Biosynex CryptoPS Test.
    Temfack E; Kouanfack C; Mossiang L; Loyse A; Fonkoua MC; Molloy SF; Koulla-Shiro S; Delaporte E; Dromer F; Harrison T; Lortholary O
    Front Microbiol; 2018; 9():409. PubMed ID: 29593675
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of the Dynamiker Cryptococcal Antigen Lateral Flow Assay for the Diagnosis of HIV-Associated Cryptococcosis.
    Kwizera R; Omali D; Tadeo K; Kasibante J; Rutakingirwa MK; Kagimu E; Ssebambulidde K; Williams DA; Rhein J; Boulware D; Meya DB
    J Clin Microbiol; 2021 Feb; 59(3):. PubMed ID: 33268538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Significance of Low Serum Cryptococcal Antigen Titers by Lateral Flow Assay in Immunocompromised Patients: a Retrospective Case-Control Study.
    Dizon E; Seo W; Butler-Wu SM; She RC
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31723013
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings.
    Meya DB; Manabe YC; Castelnuovo B; Cook BA; Elbireer AM; Kambugu A; Kamya MR; Bohjanen PR; Boulware DR
    Clin Infect Dis; 2010 Aug; 51(4):448-55. PubMed ID: 20597693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Serum Cryptococcal Antigen Testing Using Two Novel Semiquantitative Lateral Flow Assays in Persons with Cryptococcal Antigenemia.
    Skipper C; Tadeo K; Martyn E; Nalintya E; Rajasingham R; Meya DB; Kafufu B; Rhein J; Boulware DR
    J Clin Microbiol; 2020 Mar; 58(4):. PubMed ID: 32024729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Underlying Cryptococcal Diseases and the Correlation With Serum Cryptococcal Antigen Titers in Hospitalized HIV-Infected Patients Screened Positive for Cryptococcal Antigenemia.
    Xu M; Peng Z; Xu C; Chen Y; Cheng J; Chi Y; Wei H; Chen W; Hu Z
    Front Cell Infect Microbiol; 2020; 10():170. PubMed ID: 32391288
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence and outcomes of cryptococcal antigenemia in HIV-seropositive patients hospitalized for suspected tuberculosis in Uganda.
    Andama AO; den Boon S; Meya D; Cattamanchi A; Worodria W; Davis JL; Walter ND; Yoo SD; Kalema N; Haller B; Huang L;
    J Acquir Immune Defic Syndr; 2013 Jun; 63(2):189-94. PubMed ID: 23542636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing for Cryptococcosis at a Major Commercial Laboratory-United States, 2019-2021.
    Benedict K; Gold JAW; Dietz S; Anjum S; Williamson PR; Jackson BR
    Open Forum Infect Dis; 2022 Jul; 9(7):ofac253. PubMed ID: 35855002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Cryptococcus Antigen Titers as Determined by Lateral Flow Assay Should Be Interpreted Cautiously in Patients without Prior Diagnosis of Cryptococcal Infection.
    Dubbels M; Granger D; Theel ES
    J Clin Microbiol; 2017 Aug; 55(8):2472-2479. PubMed ID: 28566315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CrAg lateral flow assay for cryptococcosis.
    Kozel TR; Bauman SK
    Expert Opin Med Diagn; 2012 May; 6(3):245-51. PubMed ID: 23480688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six-month outcomes of HIV-infected patients given short-course fluconazole therapy for asymptomatic cryptococcal antigenemia.
    Kapoor SW; Magambo KA; Kalluvya SE; Fitzgerald DW; Peck RN; Downs JA
    AIDS; 2015 Nov; 29(18):2473-8. PubMed ID: 26372487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for cryptococcal antigen in asymptomatic people with HIV: urgent need in Eastern India.
    Chakravarty J; Reddy S; Gupta MK; Tilak R; Diwaker C; Sundar S
    AIDS; 2023 Dec; 37(15):2359-2363. PubMed ID: 37650766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory Reflex and Clinic-Based Point-of-Care Cryptococcal Antigen Screening for Preventing Meningitis and Mortality Among People Living With HIV.
    Drain PK; Galagan SR; Govere S; Krows M; Thulare H; Wallis CL; Gosnell BI; Moosa MY; Celum C; Bassett IV
    J Acquir Immune Defic Syndr; 2021 Aug; 87(5):1205-1213. PubMed ID: 33990495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptococcal disease in patients with or without human immunodeficiency virus: clinical presentation and monitoring of serum cryptococcal antigen titers.
    Lin TY; Yeh KM; Lin JC; Wang NC; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2009 Jun; 42(3):220-6. PubMed ID: 19812855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dynamic research of serum cryptococcal capsular polysaccharide antigen titer and chest CT of pulmonary cryptococcosis after antifungal therapy].
    Lin PC; Ye JR; Zhou Y; Zhang DQ; Xie YP; Chen CS; Li YP
    Zhonghua Yi Xue Za Zhi; 2019 Jul; 99(26):2036-2041. PubMed ID: 31315373
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of the initial 12 months of a routine cryptococcal antigen screening program in reduction of HIV-associated cryptococcal meningitis in Uganda.
    Enock K; Julius K; Griffith BC; Abila DB; Rutakingirwa MK; Kasibante J; Kandole KT; Kwizera R; Semeere A; Meya DB
    BMC Health Serv Res; 2022 Mar; 22(1):301. PubMed ID: 35246128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of the IMMY cryptococcal antigen lateral flow assay on serum and cerebrospinal fluid for diagnosis of cryptococcosis in HIV-negative patients: a systematic review.
    Macrae C; Ellis J; Keddie SH; Falconer J; Bradley J; Keogh R; Baerenbold O; Hopkins H; Jarvis JN
    BMC Infect Dis; 2023 Apr; 23(1):209. PubMed ID: 37024842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cryptococcal antigen titre as a diagnostic tool and a predictor of mortality in HIV-infected patients with cryptococcal meningitis.
    Chen J; Zhang R; Shen Y; Liu L; Qi T; Wang Z; Mehraj V; Routy JP; Lu H
    HIV Med; 2019 Jan; 20(1):69-73. PubMed ID: 30311440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of CryptoPS LFA-positive sera in patients at risk of cryptococcosis.
    Aissaoui N; Benhadid-Brahmi Y; Sturny-Leclère A; Hamane S; Payet E; Bonnal C; Munier AL; Denis B; Alanio A
    Med Mycol; 2022 Oct; 60(10):. PubMed ID: 36149324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.